LDOS · Q3 2026
Tuesday, November 3 · 8:00 AM EST
Results available
Fiscal period ended 2026-10-02.
Full analysis below.
Leidos · Q3 2026 · Earnings analysis
Lower tax expense explains most of the quarterly non-GAAP net income increase. Organic growth slows, and a smaller Corporate loss supplies nearly all the non-GAAP operating gain.
Second quarter of fiscal year 2026. Period ended 2026-07-03. Company-wide figures unless noted.
organically; the release defines organic revenues as current revenues excluding revenues from acquisitions within the last 12 months and divestitures within the current and year-ago periods
Leidos' revenue rose 4%, with 0.6% organic growth, while Homeland expanded and higher-margin Health contracted. A new joint venture figures in revised full-year guidance.
No official call questions and answers available here for this quarter.